Melanie Leveridge
Lead a department of ~200 talented scientists within Discovery Sciences accountable for assay development, cellular reagent generation and cell model development, cell banking, compound profiling (including wave 1 DMPK and early safety profiling), chemical biology, proteomics and mechanism of action studies in support of AstraZeneca’s Small Molecule and Oligonucleotide portfolio. This role is an evolution of my initial role at AstraZeneca, to bring together our assay development and compound profiling teams into a single department.